Skip to content

Evaluation of the Effect of Psycho-oncological Intervention on Well-being of Patients With Advanced Prostate Cancer on LHRH Analogs and Their Partners. A Randomized Controlled Pilot Study.

Evaluation of the Effect of Psycho-oncological Intervention on Well-being of Patients With Advanced Prostate Cancer on LHRH Analogs and Their Partners. A Randomized Controlled Pilot Study.

Status
Terminated
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01562522
Acronym
EXPEDIENT
Enrollment
6
Registered
2012-03-26
Start date
2012-03-31
Completion date
2013-07-31
Last updated
2019-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Brief summary

The purpose of the protocol, is to assess the feasibility of conducting a larger trial to evaluate the effect of a psychological intervention on the well-being of patients on luteinizing hormone-releasing hormone (LHRH) analogs in the treatment of prostate cancer and their partners.

Interventions

Attendance at 7 group sessions, consisting of 5-6 couples, preceded by an intake consultation. Total intervention time: 16 weeks.

Sponsors

Ipsen
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
MALE
Healthy volunteers
No

Inclusion criteria

* Histologically confirmed diagnosis of prostate cancer on biopsy * Locally advanced or metastasised prostate cancer in need of hormonal treatment. * On LHRH analogue treatment for a minimum of 5 months (at inclusion) * Having a female partner * Patients and their partner are able to fill out questionnaires, attend group sessions and give consent

Exclusion criteria

* Serious psychiatric difficulties * Life expectancy \< 12 months

Design outcomes

Primary

MeasureTime frameDescription
Sufficient interest in participationUp to the end of 16 weeks of the intervention periodDetermined by achievement of all of the following: * Number of participants (couples) recruited in 18 months in the participating centres. Achieved by recruitment of 50 couples. * Number of participants (couples) informed personally about the study consent to participate. To be achieved by 20% of couples. * Number of participants in group 1 that attend at least 70% of the sessions. To be achieved by 80% of participants.
Preliminary improvement in well-beingAfter the intervention period of 16 weeksImproved - Group 1 improve more than group 2 on at least one of the outcome measures (includes HADS, EORTC QLQ-C30 or Maudsley Marital Questionnaire). Worsened - Group 1 should not worsen more than group 2 on any of the outcome measures.

Secondary

MeasureTime frame
Difference in relationship satisfaction (Maudsley Marital Questionnaire)Baseline (T0), after the intervention period of 16 weeks (T1) and 1 year (T2)
Change in quality of life questionnaire QLQ-C30 scoresBaseline (T0), after the intervention period of 16 weeks (T1) and 1 year (T2)
Change in Hospital Anxiety and Depression Scale (HADS) scoresBaseline (T0), after the intervention period of 16 weeks (T1)
Difference between level of depression and anxiety (HADS)Baseline (T0) and 1 year (T2)
Change in quality of life questionnaire QLQ-PR25 scoresBaseline(T0), after the intervention period of 16 weeks (T1) and 1 year (T2)

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026